Understand the source comparison
Glow Stack Blood Work Labs: Before vs After Comparison
ALT (Alanine Aminotransferase) 10–40 U/L ≤1.2× baseline >1.5× baseline or >60 U/L Elevated ALT signals hepatocellular stress. Reduce hepatotoxic compounds or discontinue protocol Creatinine 0.7–1.3 mg/dL ≤1.1× baseline >1.3× baseline or eGFR <60 Rising creatin
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- ALT (Alanine Aminotransferase)
- 10–40 U/L
- ≤1.2× baseline
- >1.5× baseline or >60 U/L
- Elevated ALT signals hepatocellular stress. Reduce hepatotoxic compounds or discontinue protocol
- Creatinine
- 0.7–1.3 mg/dL
- ≤1.1× baseline
- >1.3× baseline or eGFR <60
- Rising creatinine indicates reduced renal clearance. Adjust peptide doses cleared via kidneys
- Free T3
- 2.3–4.2 pg/mL
- Within 10% of baseline
- <2.0 pg/mL or >20% drop
- Suppressed T3 suggests thyroid axis disruption. Evaluate for reverse T3 dominance
- Fasting Insulin
- 2–10 µIU/mL
- ≤12 µIU/mL
- >15 µIU/mL or 2× baseline
- Hyperinsulinemia indicates worsening insulin resistance. Discontinue growth-promoting peptides
- IGF-1
- 115–307 ng/mL
- <350 ng/mL
- >400 ng/mL
- Supraphysiological IGF-1 increases acromegaly and neoplastic risk. Reduce GH secretagogue dose